MPT Product Development Database

Multipurpose Prevention Technologies (MPTs) are an innovative class of products that deliver varied combinations of HIV prevention, other STI prevention, and contraception and will improve the lives of women and families worldwide.

This database includes MPT products that are currently in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Please note there are other MPT candidates not listed that may move forward pending funding. Click here to learn more about the inclusion criteria and information update methodology.

Click on the tables for MPT products in the development pipeline, listed by:
 
 
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!
 
Hormonal/Non-HormonalDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

24 product(s) found

Results: 11 product(s) found
90-day Pod-type Etonogestrel/Ethinyl Estradiol/QGriffithsin (QGRFT) Intravaginal Ring [EEQ IVR]
MPT in Development
Hormonal Topical Intravaginal Ring (IVR)
  • Etonogestrel
  • Ethinyl Estradiol
  • QGriffithsin (QGRFT)
  • Oak Crest Institute of Science
  • Population Council
  • Pre1
  • HIV
  • Pregnancy
  • Copper Intravaginal Ring (Cu-IVR)
    MPT in Development
    Non-Hormonal Topical Intravaginal Ring (IVR)
  • Copper
  • University of California, Davis
  • Pre1
  • HSV-2
  • Pregnancy
  • Zika virus (ZIKV)
  • Dapivirine + Levonorgestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • International Partnership for Microbicides (IPM)
  • C1
  • HIV
  • Pregnancy
  • Dapivirine + Pritelivir + Levonorgestrel 3D Printed IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • Pritelivir
  • University of North Carolina, Chapel Hill
  • Pre1
  • HIV
  • HSV-2
  • Pregnancy
  • Dolutegravir (DTG) + Rilpivirine (RPV) + Acyclovir + Ethinyl Estradiol + Etonogestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Dolutegravir
  • Etonogestrel
  • Ethinyl Estradiol
  • Rilpivirine
  • Auritec Pharmaceuticals
  • Pre2
  • HIV
  • HSV-2
  • Pregnancy
  • Human Contraceptive Antibody (HCA) + VRC01 + N6 IVR
    MPT in Development
    Non-Hormonal Topical Intravaginal Ring (IVR)
  • HCA
  • Monoclonal Antibodies
  • VRC01 + N6
  • MUCOMMUNE LLC
  • Pre2
  • HIV
  • Pregnancy
  • Islatravir (EFdA) + Etonogestrel/Ethinyl Estradiol 3D Printed IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Etonogestrel
  • Ethinyl Estradiol
  • Islatravir (EFdA)
  • University of North Carolina, Chapel Hill
  • Pre1
  • HIV
  • Pregnancy
  • mAb 2C7 + TDF IVR
    MPT in Development
    Non-Contraceptive Topical Intravaginal Ring (IVR)
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • MassBiologics
  • Oak Crest Institute of Science
  • Planet Biotechnology, Inc.
  • University of Massachusetts
  • Pre2
  • Gonorrhea
  • HIV
  • Novel mAb contraceptive + TDF IVR
    MPT in Development
    Non-Hormonal Topical Intravaginal Ring (IVR)
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • Oak Crest Institute of Science
  • University of North Carolina, Chapel Hill
  • Pre1
  • HIV
  • Pregnancy
  • Tenofovir + Levonorgestrel IVR
    MPT in Development
    Hormonal Topical Intravaginal Ring (IVR)
  • Levonorgestrel
  • Tenofovir (TFV)
  • CONRAD
  • C2
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir IVR
    MPT in Development
    Non-Contraceptive Topical Intravaginal Ring (IVR)
  • Tenofovir (TFV)
  • CONRAD
  • C2
  • HIV
  • HSV-2
  • IMPT Secretariat
    1750 Howe Avenue, Suite 550
    Sacramento, CA 95825
    IMPT@cami-health.org

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

    © Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.